Johnson Investment Counsel’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,622
| Closed | -$618K | – | 692 |
|
|
2022
Q4 | $618K | Hold |
18,622
| – | – | 0.01% | 419 |
|
|
2022
Q3 | $587K | Hold |
18,622
| – | – | 0.01% | 406 |
|
|
2022
Q2 | $566K | Hold |
18,622
| – | – | 0.01% | 421 |
|
|
2022
Q1 | $483K | Sell |
18,622
-500
| -3% | -$11.9K | 0.01% | 474 |
|
|
2021
Q4 | $390K | Hold |
19,122
| – | – | ﹤0.01% | 510 |
|
|
2021
Q3 | $368K | Sell |
19,122
-1,000
| -5% | -$19.9K | ﹤0.01% | 506 |
|
|
2021
Q2 | $446K | Hold |
20,122
| – | – | 0.01% | 465 |
|
|
2021
Q1 | $528K | Sell |
20,122
-4,000
| -17% | -$95.1K | 0.01% | 409 |
|
|
2020
Q4 | $451K | Sell |
24,122
-1,975
| -8% | -$36.9K | 0.01% | 416 |
|
|
2020
Q3 | $443K | Buy |
26,097
+7,695
| +42% | +$150K | 0.01% | 403 |
|
|
2020
Q2 | $429K | Buy |
+18,402
| New | +$267K | 0.01% | 406 |
|
|
2020
Q1 | – | Sell |
-21,168
| Closed | -$207K | – | 622 |
|
|
2019
Q4 | $207K | Buy |
21,168
+1,251
| +6% | +$11.7K | ﹤0.01% | 568 |
|
|
2019
Q3 | $189K | Hold |
19,917
| – | – | ﹤0.01% | 572 |
|
|
2019
Q2 | $236K | Buy |
19,917
+2,548
| +15% | +$30.7K | ﹤0.01% | 551 |
|
|
2019
Q1 | $305K | Hold |
17,369
| – | – | 0.01% | 498 |
|
|
2018
Q4 | $301K | Buy |
17,369
+2,452
| +16% | +$41.8K | 0.01% | 479 |
|
|
2018
Q3 | $222K | Hold |
14,917
| – | – | ﹤0.01% | 576 |
|
|
2018
Q2 | $237K | Hold |
14,917
| – | – | 0.01% | 567 |
|
|
2018
Q1 | $211K | Sell |
14,917
-1,373
| -8% | -$20.3K | 0.01% | 579 |
|
|
2017
Q4 | $228K | Hold |
16,290
| – | – | 0.01% | 559 |
|
|
2017
Q3 | $232K | Hold |
16,290
| – | – | 0.01% | 559 |
|
|
2017
Q2 | $256K | Buy |
16,290
+3,863
| +31% | +$55.6K | 0.01% | 541 |
|
|
2017
Q1 | $171K | Sell |
12,427
-12,850
| -51% | -$180K | ﹤0.01% | 587 |
|
|
2016
Q4 | $447K | Sell |
25,277
-248
| -1% | -$4.36K | 0.01% | 398 |
|
|
2016
Q3 | $492K | Hold |
25,525
| – | – | 0.02% | 348 |
|
|
2016
Q2 | $497K | Hold |
25,525
| – | – | 0.02% | 345 |
|
|
2016
Q1 | $526K | Sell |
25,525
-400
| -2% | -$7.88K | 0.02% | 322 |
|
|
2015
Q4 | $531K | Buy |
25,925
+248
| +1% | +$4.75K | 0.02% | 312 |
|
|
2015
Q3 | $439K | Sell |
25,677
-225
| -0.9% | -$4.11K | 0.02% | 352 |
|
|
2015
Q2 | $482K | Hold |
25,902
| – | – | 0.02% | 331 |
|
|
2015
Q1 | $494K | Hold |
25,902
| – | – | 0.02% | 323 |
|
|
2014
Q4 | $426K | Sell |
25,902
-2,150
| -8% | -$36.9K | 0.01% | 361 |
|
|
2014
Q3 | $496K | Buy |
28,052
+225
| +0.8% | +$4.42K | 0.02% | 316 |
|
|
2014
Q2 | $574K | Hold |
27,827
| – | – | 0.02% | 264 |
|
|
2014
Q1 | $606K | Sell |
27,827
-725
| -3% | -$16.6K | 0.02% | 248 |
|
|
2013
Q4 | $757K | Hold |
28,552
| – | – | 0.03% | 224 |
|
|
2013
Q3 | $674K | Buy |
28,552
+200
| +0.7% | +$4.67K | 0.03% | 223 |
|
|
2013
Q2 | $609K | Buy |
+28,352
| New | +$611K | 0.03% | 229 |
|
Other funds holding VIVO
Johnson Investment Counsel's VIVO Position: Q1 2023 in Review
Johnson Investment Counsel sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 18,622 shares — an estimated $618K sold.
Johnson Investment Counsel first reported a position in VIVO in Q2 2013 and held it in 38 quarters. The position peaked at $757K in Q4 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Johnson Investment Counsel reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Johnson Investment Counsel sold 18,622 Meridian Bioscience Inc shares in Q1 2023, an estimated $618K.
- Johnson Investment Counsel first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 38 quarters.
- Johnson Investment Counsel's Meridian Bioscience Inc position peaked at $757K in Q4 2013.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Johnson Investment Counsel's 13F filing for Q1 2023, filed 15 May 2023.